Abbott Laboratories – Company Information
Abbott Laboratories – Company Overview
|Headquarters||100 Abbott Park Road Abbott Park, IL 60064-3500, USA|
|Chairman and CEO||Miles D. White|
|CFO||Brian B. Yoor|
|Founder||Dr. Wallace Calvin Abbott|
|Founded||1888 (as Abbott Alkaloidal Company)|
|NYSE stock symbol||ABT|
|Net Sales||$20,405 million USD (2015)|
|Net earnings||$4,423 million USD (2015)|
|Earnings per share||$2.94 USD (2015)|
|Contact number||(224) 667-6100|
Abbott Laboratories is a pharmaceutical manufacturing company based in Chicago, USA. It was originally founded by Dr. Wallace Calvin Abbott in 1888.
After Dr Abbott graduated from University of Michigan.
In 1885 he began practicing medicine, started running his own drug store, and formed the “Abbott Alkaloidal Company”.
His vision was to create the most effective dosages possible for patients by using a technique which involved “dosimetric granules”.
As of February 2014, Abbott Laboratories is a Fortune 200 company that operates in more than 150 countries, with approximately 90,000 employees worldwide.
The company has a very strong worldwide presence as most of its employees work outside the US and the majority of its sales are outside the US too.
In 2013, Abbott split into two separate companies: Abbott and AbbVie (a biopharmaceutical company).
According to Miles D. White, the Chairman and CEO of Abbott:
“About 70 percent of our sales are now outside the United States, with 40 percent coming from the fastest-growing economies. And that’s reflected in our employee population, with 65 percent of our approximately 70,000 colleagues working outside the United States, as well.”
Abbott Laboratories has four main businesses focuses, including: diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals.
The company’s diverse range of products include:
- Diagnostic products – tools to help doctors make the right treatment decisions.
- Vascular products – vascular devices that help treat cardiac and vascular disease.
- Diabetes care products – blood glucose monitoring systems.
- Vision technologies – laser vision correction and cataract technologies.
- Nutritional products – products formulated that promote healthy growth and development as well as managing the nutritional needs of patients with diseases such as cancer or diabetes.
- Pharmaceuticals – a range of pharmaceutical products, including some of the best selling drugs in the world: Klacid (a macrolide antibiotic), Brufen (branded ibuprofen) and Duphaston (branded progesterone). The company’s main therapeutic areas are: cardiovascular, women’s health, gastroenterology, primary care, and metabolic disorders.
Abbott Laboratories’ production plants are located all over the world (Source: Abbott).
Abbott Laboratories – Financial Results
|Operating data (in $ millions USD)||2015*||2014*|
|Total operating cost and expenses||$17,538||$17,648|
|Earnings from continuing operations before taxes||$3,183||$2,518|
|Earnings from continuing operations||$2,606||$1,721|
|Balance sheet data (in $ millions USD)|
|Total shareholders’ investment||$21,326||$21,639|
|Common share data (in $ USD)|
|Basic earnings per share||$2.94||$1.50|
|Diluted earnings (loss) per share||$2.92||$1.49|
|Cash flow data (in $ millions USD)|
|Net cash from operating activities||$2,966||$3,675|
|Net cash from (used in) investing activities||$406||$(202)|
|Net cash (used in) from financing activities||$(2,236)||$(2,742)|
|Cash and cash equivalents at beginning of year||$4,063||$3,475|
|Cash and cash equivalents at end of year||$5,001||$4,063|
*Years Ended December 31